Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Phytother Res ; 25(8): 1246-9, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21796699

RESUMEN

Bioactivity-directed fractionation of the MeOH fraction of the extract of Mimulus bigelovii by means of an axenic Leishmania amastigote assay and chromatographic techniques resulted in the isolation of four C-geranyl flavanones, diplacone (1), 3'-O-methyldiplacone (2), 4'-O-methyldiplacone (3), 3'-O-methyldiplacol (4), together with a geranylated flavone, cannflavin A (5). These compounds were separated from M. bigelovii for the first time. All compounds showed moderate antileishmanial activity against axenic Leishmania donovani amastigotes with IC(50) values ranging from 4.8 to 14.6 µg/mL. The compounds were also tested against the related kinetoplastid parasite Trypanosoma brucei brucei and they showed activity with IC(50) values ranging from 1.4 to 7.2 µg/mL.


Asunto(s)
Antiprotozoarios/farmacología , Flavonoides/farmacología , Leishmania donovani/efectos de los fármacos , Mimulus/química , Trypanosoma brucei brucei/efectos de los fármacos , Antiprotozoarios/aislamiento & purificación , California , Flavanonas/farmacología , Flavonas/farmacología , Flavonoides/aislamiento & purificación , Flores/química , Frutas/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta/química , Raíces de Plantas/química , Tallos de la Planta/química
2.
Chem Biol Drug Des ; 78(1): 183-9, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21457471

RESUMEN

In vitro leishmanicidal activity of 16 N-benzylcytisine derivatives has been evaluated using Leishmania donovani axenic amastigotes. In general, halogen (bromo-, chloro-) derivatives appeared to be more toxic against parasites than their parent compounds. Quantum-chemical calculations helped to recognize certain patterns in the structure of frontier orbitals related to bioactivity of compounds. Thus, the presence of halogen atom is shown to have a significant effect on both distribution and the energy of LUMOs thereby on potent activity that was also confirmed by Quantitative-Structure Activity Relationship (QSAR) analysis. Experimentally and theoretically observed structure-cytotoxicity relationships are described.


Asunto(s)
Antiprotozoarios/química , Antiprotozoarios/farmacología , Leishmania donovani/efectos de los fármacos , Quinolizinas/química , Quinolizinas/farmacología , Animales , Concentración 50 Inhibidora , Modelos Moleculares , Relación Estructura-Actividad Cuantitativa
3.
Bioorg Med Chem ; 12(11): 2815-24, 2004 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-15142541

RESUMEN

A series of 5-thiocyanatomethyl- and 5-alkyl-3-aryl-1,2,4-oxadiazoles were synthesized and evaluated for their activity against kinetoplastid parasites. Formation of the oxadiazole ring was accomplished through the reaction of benzamidoximes with acyl chlorides, while the thiocyanate group was inserted by reacting the appropriate 5-halomethyl oxadiazole with ammonium thiocyanate. The thiocyanate-containing compounds possessed low micromolar activity against Leishmania donovani and Trypanosoma brucei, while the 5-alkyl oxadiazoles were less active against these parasites. 3-(4-Chlorophenyl)-5-(thiocyanatomethyl)-1,2,4-oxadiazole (compound 4b) displayed modest selectivity for L. donovani axenic amastigote-like parasites over J774 macrophages, PC3 prostate cancer cells, and Vero cells (6.4-fold, 3.8-fold, and 9.1-fold, respectively), while 3-(3,4-dichlorophenyl)-5-(thiocyanatomethyl)-1,2,4-oxadiazole (compound 4 h) showed 30-fold selectivity against Vero cells but was not selective against PC3 cells. In a murine model of visceral leishmaniasis, compound 4b decreased liver parasitemia caused by L. donovani by 48% when given in five daily i.v. doses at 5mg/kg and by 61% when administered orally for 5 days at 50 mg/kg. These results indicate that aromatic thiocyanates hold promise for the treatment of leishmanial infections if the selectivity of these compounds can be improved.


Asunto(s)
Antiprotozoarios/química , Antiprotozoarios/farmacología , Leishmania donovani/efectos de los fármacos , Oxadiazoles/farmacología , Tiocianatos/farmacología , Trypanosoma brucei brucei/efectos de los fármacos , Animales , Antiprotozoarios/síntesis química , Línea Celular , Ratones , Oxadiazoles/síntesis química , Oxadiazoles/química , Oxadiazoles/metabolismo , Tiocianatos/síntesis química , Tiocianatos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA